Matthew Hamilton Rosenberg’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.5K | Hold |
2,104
| – | – | 0.01% | 499 |
|
|
2025
Q1 | $31.3K | Hold |
2,104
| – | – | 0.01% | 487 |
|
|
2024
Q4 | $27.9K | Hold |
2,104
| – | – | 0.01% | 494 |
|
|
2024
Q3 | $29.9K | Buy |
2,104
+543
| +35% | +$7.72K | 0.01% | 503 |
|
|
2024
Q2 | $20.3K | Sell |
1,561
-1,086
| -41% | -$14.1K | 0.01% | 529 |
|
|
2024
Q1 | $36.2K | Hold |
2,647
| – | – | 0.01% | 470 |
|
|
2023
Q4 | $37.8K | Sell |
2,647
-729
| -22% | -$10.4K | 0.01% | 465 |
|
|
2023
Q3 | $52.2K | Buy |
3,376
+337
| +11% | +$5.21K | 0.02% | 410 |
|
|
2023
Q2 | $47.7K | Buy |
3,039
+321
| +12% | +$5.04K | 0.02% | 437 |
|
|
2023
Q1 | $44.8K | Hold |
2,718
| – | – | 0.01% | 484 |
|
|
2022
Q4 | $42.4K | Buy |
2,718
+11
| +0.4% | +$172 | 0.01% | 500 |
|
|
2022
Q3 | $35K | Buy |
2,707
+13
| +0.5% | +$168 | 0.01% | 519 |
|
|
2022
Q2 | $38K | Hold |
2,694
| – | – | 0.01% | 517 |
|
|
2022
Q1 | $39K | Hold |
2,694
| – | – | 0.01% | 491 |
|
|
2021
Q4 | $37K | Sell |
2,694
-5,179
| -66% | -$71.1K | 0.01% | 463 |
|
|
2021
Q3 | $129K | Buy |
7,873
+462
| +6% | +$7.57K | 0.05% | 246 |
|
|
2021
Q2 | $125K | Buy |
7,411
+477
| +7% | +$8.05K | 0.07% | 221 |
|
|
2021
Q1 | $127K | Buy |
6,934
+586
| +9% | +$10.7K | 0.07% | 214 |
|
|
2020
Q4 | $115K | Sell |
6,348
-2,360
| -27% | -$42.8K | 0.07% | 210 |
|
|
2020
Q3 | $155K | Buy |
8,708
+10
| +0.1% | +$178 | 0.11% | 115 |
|
|
2020
Q2 | $156K | Buy |
8,698
+3,155
| +57% | +$56.6K | 0.12% | 109 |
|
|
2020
Q1 | $85K | Buy |
+5,543
| New | +$85K | 0.08% | 158 |
|